Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
Term & termination | Term of agreement
Provision Language
Definitions
“Royalty Term” means, separately with respect to each Licensed Product in each country, the period (a) commencing on the First Commercial Sale of such Licensed Product in such country (provided that either (i) such Licensed Product is covered by an Outstanding Claim of a UBC Controlled Patent Right in such country, or (ii) the manufacture of such Licensed Product is covered by an Outstanding Claim of a UBC Controlled Patent Right in the country or countries of manufacture, in each case at the time of such First Commercial Sale in such country), and (b) concluding on the expiration of the latest of (i) the last to expire Valid Claim of a UBC Controlled Patent Right in such country covering such Licensed Product, (ii) the last to expire Valid Claim of a UBC Controlled Patent Right in the country or countries of manufacture of such Licensed Product covering such Licensed Product, and (iii) twelve (12) years from the date of First Commercial Sale of such Licensed Product in such country.
10. Expiration and Termination
10.1 Agreement Term. The term of this Agreement (the “Agreement Term”) will begin on the Effective Date and unless earlier terminated in accordance with this Section 10, shall remain in effect until the expiration of the last–to–expire Royalty Term for a Licensed Product.
Charles B. Holmes, MD, MPH, FIDSA, a physician and global health leader with more than 25 years of experience, brings expertise in public health policy, strengthening health systems, and the introduction and scale-up of health innovations. As Director of the Center for Innovation in Global Health at Georgetown University and Senior Advisor to Gates Medical Research Institute, he works at the intersection of science, policy, and implementation to improve health outcomes globally. His leadership experience includes serving as Chief Medical Officer and Deputy U.S. Global AIDS Coordinator at PEPFAR, Chief Executive Officer of CIDRZ in Zambia, and senior roles across academia, government, and industry. His experience building partnerships across countries, institutions, and sectors positions him to support GHIAA’s mission of advancing equitable and sustainable access to health innovations worldwide.
Sign Up to Our Newsletter
Receive updates about GHIAA’s latest tools, resources and news.
